Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tales From HIMSS23: FDA On FHIR And AI For The Voiceless

Executive Summary

A series of stories from the Healthcare Information and Management Society's 2023 Global Health Conference.

You may also be interested in...



News We’re Watching: Smart Watch Blood Glucose Warning, $100M For Women’s Health, Zimmer Surgical Robot Clearance

This week, the FDA reminded consumers that smart watches and rings are not blood glucose monitors; First Lady Jill Biden announced a $100M women’s health initiative; and the Zimmer ROSA Shoulder System got FDA clearance.

AdvaMed Principles For Artificial Intelligence Focus On Patient, Physician Needs

AdvaMed’s principles for artificial intelligence deb focus on using the technology to meet patient needs.

Da Vinci Surgical Robot Insulation Defects Led To Florida Woman’s Death, Lawsuit Alleges

Intuitive Surgical is facing claims that malfunctions of its da Vinci surgical robot led to a woman’s death following a laparoscopic surgery.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT147837

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel